1. Home
  2. LEGN vs GLBE Comparison

LEGN vs GLBE Comparison

Compare LEGN & GLBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • GLBE
  • Stock Information
  • Founded
  • LEGN 2014
  • GLBE 2013
  • Country
  • LEGN United States
  • GLBE Israel
  • Employees
  • LEGN N/A
  • GLBE N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • GLBE Computer Software: Prepackaged Software
  • Sector
  • LEGN Health Care
  • GLBE Technology
  • Exchange
  • LEGN Nasdaq
  • GLBE Nasdaq
  • Market Cap
  • LEGN 5.4B
  • GLBE 6.1B
  • IPO Year
  • LEGN 2020
  • GLBE 2021
  • Fundamental
  • Price
  • LEGN $28.95
  • GLBE $31.87
  • Analyst Decision
  • LEGN Strong Buy
  • GLBE Strong Buy
  • Analyst Count
  • LEGN 12
  • GLBE 13
  • Target Price
  • LEGN $77.09
  • GLBE $50.38
  • AVG Volume (30 Days)
  • LEGN 1.9M
  • GLBE 2.8M
  • Earning Date
  • LEGN 05-13-2025
  • GLBE 05-14-2025
  • Dividend Yield
  • LEGN N/A
  • GLBE N/A
  • EPS Growth
  • LEGN N/A
  • GLBE N/A
  • EPS
  • LEGN N/A
  • GLBE N/A
  • Revenue
  • LEGN $728,303,000.00
  • GLBE $796,773,000.00
  • Revenue This Year
  • LEGN $64.21
  • GLBE $27.09
  • Revenue Next Year
  • LEGN $53.69
  • GLBE $25.12
  • P/E Ratio
  • LEGN N/A
  • GLBE N/A
  • Revenue Growth
  • LEGN 112.46
  • GLBE 33.20
  • 52 Week Low
  • LEGN $27.34
  • GLBE $26.64
  • 52 Week High
  • LEGN $60.87
  • GLBE $63.69
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 41.56
  • GLBE 40.66
  • Support Level
  • LEGN $28.13
  • GLBE $31.13
  • Resistance Level
  • LEGN $29.31
  • GLBE $32.62
  • Average True Range (ATR)
  • LEGN 1.63
  • GLBE 1.43
  • MACD
  • LEGN 0.03
  • GLBE -0.34
  • Stochastic Oscillator
  • LEGN 27.01
  • GLBE 8.10

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About GLBE Global-E Online Ltd.

Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from and anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.

Share on Social Networks: